Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 1
2005 1
2008 2
2009 4
2010 5
2011 5
2012 17
2013 14
2014 15
2015 20
2016 12
2017 13
2018 10
2019 14
2020 16
2021 21
2022 8
2023 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33813420

145 results
Results by year
Filters applied: . Clear all
Page 1
How Much Daily Image-guided Volumetric Modulated Arc Therapy Is Useful for Proctitis Prevention With Respect to Static Intensity Modulated Radiotherapy Supported by Topical Medications Among Localized Prostate Cancer Patients?
Ferini G, Tripoli A, Molino L, Cacciola A, Lillo S, Parisi S, Umina V, Illari SI, Marchese VA, Cravagno IR, Borzì GR, Valenti V. Ferini G, et al. Anticancer Res. 2021 Apr;41(4):2101-2110. doi: 10.21873/anticanres.14981. Anticancer Res. 2021. PMID: 33813420
Interfractional Rectal Displacement Requiring Repeated Precaution Did Not Correlate to Biochemical Control and Rectal Toxicity in Patients with Prostate Cancer Treated with Image-guided Intensity-modulated Radiation Therapy.
Iwama K, Yamazaki H, Shimizu D, Suzuki G, Nakamura S, Sasaki N, Takeneka T, Okabe H, Nishikawa T, Yoshida K. Iwama K, et al. Anticancer Res. 2017 Oct;37(10):5755-5760. doi: 10.21873/anticanres.12015. Anticancer Res. 2017. PMID: 28982897
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.
Fersino S, Tebano U, Mazzola R, Giaj-Levra N, Ricchetti F, Di Paola G, Fiorentino A, Sicignano G, Naccarato S, Ruggieri R, Cavalleri S, Alongi F. Fersino S, et al. Clin Genitourin Cancer. 2017 Aug;15(4):e667-e673. doi: 10.1016/j.clgc.2017.01.025. Epub 2017 Feb 6. Clin Genitourin Cancer. 2017. PMID: 28237181
145 results